Anastasios Stathis
@AnastasiosStat2
Followers
131
Following
385
Media
2
Statuses
69
Medical Oncologist. Head-Phase I Program, Oncology Institute of Southern Switzerland. Professor-Università della Svizzera Italiana.
Bellinzona, CH
Joined September 2017
MDICT 2024 recommendations for neoadjuvant early clinical trials now published. Led by ESMO-TAT chairs @lillian_siu @ElenaGarralda @AnastasiosStat2 and MDICT’24 team supported by @myESMO
https://t.co/RZdCpG0iWG
0
6
8
Great session this afternoon on #oncology #drug development 💉💊 #Biotech status & prospects Fruitful live discussion & interaction #ESMOTAT24
0
3
8
#ESMOTAT2023 starting. Amazing agenda and very excited to see so many attendees from all over the world in this important drug development meeting👏👏👏
0
4
29
ESMO announces Funda Meric-Bernstam as the recipient of 2024 TAT Honorary Award for her outstanding contributions to #PrecisionOncology. 📅 She will deliver her award lecture on 26 February at the #ESMOTAT24 in Paris 📌 https://t.co/tU4ihu42zE.
0
6
24
#ESMOTAT24: Early registration deadline 📢⏲️ 10 January 2024 at 23:59 (CET). Watch @LSeymourMD, Shivaani Kummar, Irene Braña, Timothy Yap, @lillian_siu, @ElenaGarralda & @AnastasiosStat2 give their takes on why you should attend. 👇 https://t.co/Z7y9otbFyQ
0
5
8
#ESMOTAT24: Last few hours to make sure you are part of this international multi-stakeholder forum in the early drug development arena. ⏰Abstract submission deadline today (28/11, 21:00 CET) https://t.co/x14Z9dn28y
@lillian_siu @ElenaGarralda @AnastasiosStat2
1
6
9
#ESMOTAT24: Be part of this international multi-stakeholder forum in the early drug development arena! Merit travel grants are available. ⏰Abstract submission deadline: 28 November 2023. https://t.co/Flg1468uaH
@lillian_siu @ElenaGarralda @AnastasiosStat2
0
10
21
#ESMOTAT24: Shape the future of cancer #drugdevelopment and take part in this unique forum gathering all relevant stakeholders in #oncology. ⏰Abstract submission deadline: 28 November 2023. https://t.co/lsqGSsH3Rq
@lillian_siu @ElenaGarralda @AnastasiosStat2
0
2
13
#ESMOTAT24 taking place Feb 26-28, 2024, in Paris! Abstract submission now open till Nov 28, 2023: https://t.co/DyPdB0b9xO
@myESMO New meeting features with parallel industry sessions - not to be missed
0
11
29
Dall’EOC cinque nuovi Professori titolari per la Facoltà di scienze biomediche dell’USI. Comunicato stampa: https://t.co/4bRTIoAkRG
0
1
4
📢🗓The #17ICML Scientific Program, based on more than 800 submitted abstracts, is almost ready! Watch the video to have a sneak peek of the 17-ICML and stay tuned!
0
5
16
The abstract of the other one of our two #AACR23 #lymphoma posters. @IOR_Bellinzona @USI_en @EnteOspedaliero @CascioneLuciano @AnastasiosStat2 @SpexisAg Adding CXCR4 inhibition to improve activity of anti-lymphoma agents: https://t.co/BGhm68s1z3
0
2
3
The abstract of one of our two #AACR23 #lymphoma posters. @IOR_Bellinzona @USI_en @EnteOspedaliero @CascioneLuciano @AnastasiosStat2 @ManelEsteller ERBB4 as resistance to BTK and PI3K inhibitors in lymphomas: https://t.co/amUYwAoaWn
0
1
6
Tat esmo paris the ladies congratulation for2023 and next years 2024,25,26 in paris
2
2
8
Even at 8 am 🌅 really important and interactive discussion about data integrity and AI at #ESMOTAT23 workshop with @myESMO #YOC ! Thank you @recnac1 and @rsnfehrmann for amazing talks and discussion! @EMariamidze
2
4
19
2022 MDICT recommendations discussed at #ESMOTAT23 highlight the need to rethink how research studies are conducted and for multi-stakeholder collaboration. Full article available 📌 https://t.co/mEQPfzHMLH
@rdienstmann
0
4
8
0
3
23
#ESMOTAT23 opens tomorrow (6/3) bringing together communities developing the most promising new cancer drugs. Keep an eye on the hashtag for the latest news 🙂 https://t.co/Ovwzsgds3O
@lillian_siu @AnastasiosStat2 #epigenetics #immunotherapy #celltherapies #precisiononcology
1
6
17
.@myESMO & @AACR & @ESOncology joint conf on lymphoma (organised by @IOR_Bellinzona ). A complementary partnership ! Lymphoma has become complex and conf require oncol, haem but also translational/basic scientists & research Organisations. This is the future of conferences
Submit an abstract by March 15 for the 17th International Conference on Malignant Lymphoma (June 13-17; Lugano Switzerland), organized by @IOR_Bellinzona in cooperation with the AACR, @ESOncology, and @myESMO. Learn more: https://t.co/Mn5EmXzosX
#17ICML
0
2
15
W/ a record-breaking no of abstracts submitted, #ESMOTAT23 promises to be the most exciting edition to date. Register now & connect w/ leaders from academia & industry developing the latest anticancer therapies. Deadline: 18/1 https://t.co/Fom6r6B0Kf
@lillian_siu @AnastasiosStat2
0
6
10